Evidence map›Paper›PMID 8760793›Full record

ArticleThe Journal of experimental medicine1996

Cytokine transcriptional events during helper T cell subset differentiation.

J A Lederer, V L Perez, L DesRoches, S M Kim, A K Abbas, A H Lichtman

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 170 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Signal transducer and activator of transcription-6 (STAT6) inhibition suppresses renal cyst growth in polycystic kidney disease.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

J A LedererDepartment of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
V L Perez
L DesRoches
S M Kim
A K Abbas
A H Lichtman
Brigham and Women's Hospital · US

Funding

VASCULAR, PULMONARY AND RENAL INJURYT32HL007627 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GIMBRONE, MICHAEL A, MITCHELL, RICHARD N · 1985 to 2019
$12.7M
FUNCTION AND ACTIVATION OF HELPER T LYMPHOCYTESR37AI025022 · NIAID · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI ABBAS, ABUL K. · 1994 to 2003
$1.2M
FUNCTION AND ACTIVATION OF HELPER T LYMPHOCYTESR01AI025022 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI ABBAS, ABUL K. · 1987 to 1991
–
NHLBI NIH HHS T32HL07627NIAID NIH HHS AI-25022
6 · The paper itself

Abstract

The molecular basis for changes in cytokine expression during T helper (Th) cell subset differentiation is not well understood. We have characterized transcriptional events related to cytokine gene expression in populations of naive T cell receptor-transgenic T cells as they are driven in vitro toward Th1 or Th2 phenotypes by interleukin (IL)-12 or IL-4 treatment, respectively. Quantitative reverse transcriptase-polymerase chain reaction analysis of cytokine transcripts indicates that interferon (IFN) gamma, IL-4, and IL-2 mRNA are expressed with distinct kinetics after naive T cells are stimulated with antigen and either IL-4 or IL-12. IFN-gamma mRNA appears as early as 6 h in IL-12-treated cultures, IL-4 appears only after 48 h in IL-4-treated cultures, and IL-2 is equivalently expressed in both types of cultures. Analyses were performed to determine if there were any differences in activation of IL-2 or IL-4 transcription factors that accompanied Th1 versus Th2 differentiation. These studies demonstrated that signal transducer and activator of transcription 6 (STAT6) binds to a sequence in the IL-4 promoter and that this STAT6-binding site can support IL-4-dependent transcription of a linked heterologous promoter. Prolonged activation of STAT6 is characteristic of populations undergoing Th2 differentiation. Furthermore, STAT6 is activated in an autocrine manner when differentiated Th2 populations are stimulated by antigen receptor ligation. Th1 populations derived from IL-12 plus antigen treatment of naive T cells remain responsive to IL-4 as indicated by induction of STAT6 and IL-4 mRNA. These data indicate that Th1 and Th2 differentiation represents the combination of different, apparently independently regulated transcriptional events. Furthermore, among transcription factors that bind to the IL-4 or IL-2 promoters, STAT6 is the one whose activation distinguishes Th2 versus Th1 development.

Indexed as

AnimalsBase SequenceCD4-Positive T-LymphocytesCell DifferentiationCytokinesDNA-Binding ProteinsInterferon-gammaInterleukin-12Interleukin-2Interleukin-4MiceMice, TransgenicMolecular Sequence DataNuclear ProteinsOligodeoxyribonucleotidesPromoter Regions, GeneticCytokinesDNA-Binding ProteinsInterferon-gammaInterleukin-12Interleukin-2Interleukin-4Nuclear ProteinsOligodeoxyribonucleotidesRNA, MessengerStat6 protein, mouseSTAT6 Transcription FactorTrans-ActivatorsTranscription Factors

Identifiers

PMID8760793
PMCPMC2192740
OpenAlexW2154354642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.